HSBC Holdings’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $199K | Sell |
13,308
-17,429
| -57% | -$260K | ﹤0.01% | 2218 |
|
|
2025
Q1 | $542K | Buy |
30,737
+2,902
| +10% | +$51.1K | ﹤0.01% | 1607 |
|
|
2024
Q4 | $487K | Sell |
27,835
-13,981
| -33% | -$245K | ﹤0.01% | 1800 |
|
|
2024
Q3 | $579K | Sell |
41,816
-7,178
| -15% | -$99.3K | ﹤0.01% | 1577 |
|
|
2024
Q2 | $397K | Sell |
48,994
-4,482
| -8% | -$36.3K | ﹤0.01% | 1764 |
|
|
2024
Q1 | $412K | Buy |
53,476
+3,836
| +8% | +$29.6K | ﹤0.01% | 1815 |
|
|
2023
Q4 | $450K | Buy |
49,640
+5,763
| +13% | +$52.2K | ﹤0.01% | 1666 |
|
|
2023
Q3 | $404K | Buy |
43,877
+22,106
| +102% | +$204K | ﹤0.01% | 1607 |
|
|
2023
Q2 | $337K | Buy |
21,771
+6,770
| +45% | +$105K | ﹤0.01% | 1691 |
|
|
2023
Q1 | $338K | Buy |
15,001
+3,080
| +26% | +$69.4K | ﹤0.01% | 1767 |
|
|
2022
Q4 | $248K | Buy |
+11,921
| New | +$248K | ﹤0.01% | 2199 |
|
|
2021
Q1 | – | Sell |
-12,778
| Closed | -$347K | – | 2608 |
|
|
2020
Q4 | $347K | Buy |
+12,778
| New | +$347K | ﹤0.01% | 2054 |
|
|
2020
Q3 | – | Sell |
-12,453
| Closed | -$254K | – | 2369 |
|
|
2020
Q2 | $254K | Sell |
12,453
-2,131
| -15% | -$43.5K | ﹤0.01% | 1843 |
|
|
2020
Q1 | $209K | Sell |
14,584
-3,206
| -18% | -$45.9K | ﹤0.01% | 1860 |
|
|
2019
Q4 | $254K | Buy |
+17,790
| New | +$254K | ﹤0.01% | 2146 |
|